Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
CNS Oncology|October 25, 2023
Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literatureJoshua D Preston, Caroline S Jansen, Siddhartha Kosaraju, et al.
Transfusion|September 3, 2015
Plerixafor in combination with granulocyte-colony-stimulating factor after chemotherapy increases mobilization efficiency in patients with lymphoma or myeloma: results of a Phase II clinical trialNeera Jagirdar, R Donald Harvey, Ajay Nooka, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 4, 2023
Characterizing Outcomes in Visceral Cutaneous T-Cell Lymphoma: A Single Center Retrospective StudyTony Zibo Zhuang, Ashley McCook-Veal, Jeffrey Switchenko, et al.
Leukemia & Lymphoma|May 7, 2010
Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous cathetersHa Tran, Martha Arellano, Abbas Chamsuddin, et al.
British Journal of Haematology|May 4, 2022
The disease course of Castleman disease patients with fatal outcomes in the ACCELERATE registryDavid C Fajgenbaum, Sheila K Pierson, Karan Kanhai, et al.
Cancer|January 17, 2020
Clustering of cutaneous T-cell lymphoma is associated with increased levels of the environmental toxins benzene and trichloroethylene in the state of GeorgiaLindsay Clough, A Rana Bayakly, Kevin C Ward, et al.
Annals of Hematology|October 20, 2021
Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphomaMridula Krishnan, R Gregory Bociek, Michelle Fanale, et al.
Transfusion|February 22, 2011
A randomized clinical trial comparing granulocyte-colony-stimulating factor administration sites for mobilization of peripheral blood stem cells for patients with hematologic malignancies undergoing autologous stem cell transplantationHeather Renfroe, Mike Arnold, Louette Vaughn, et al.
Cancer|December 11, 2019
Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 studyJonathon B Cohen, Lai Wei, Kami J Maddocks, et al.
Transfusion|May 26, 2012
A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphomaJonathan L Kaufman, Christopher R Flowers, Karen D Rados, et al.
Pageof 8